论文部分内容阅读
目的:研究厄贝沙坦与氨氯地平治疗2型糖尿病合并高血压、高尿酸的临床效果。方法:选择我院接收的2型糖尿病合并高血压、高尿酸患者46例作为研究对象,将患者分为观察组和对照组,均为23例,对照组患者应用厄贝沙坦进行治疗,观察组患者联用厄贝沙坦与氨氯地平进行治疗,对两组的治疗效果进行比较。结果:治疗后,两组患者的SBP、DBP水平均优于治疗前,有统计学意义(P<0.05);治疗后,观察组患者的SBP、DBP水平和血尿酸均优于对照组;观察组治疗总有效率高于对照组。结论:临床上联合应用厄贝沙坦与氨氯地平治疗2型糖尿病合并高血压、高尿酸的临床效果较好,能够有效控制患者血糖、血压和血尿酸的状况,加强了对患者肾脏功能的保护,值得应用。
Objective: To study the clinical efficacy of irbesartan and amlodipine in the treatment of type 2 diabetes complicated with hypertension and hyperuricaemia. Methods: Forty-six patients with type 2 diabetes mellitus complicated with hypertension and hyperuricaemia who received in our hospital were selected as study subjects. The patients were divided into observation group and control group, all of which were in 23 cases. The patients in control group were treated with irbesartan and observed Group of patients combined with irbesartan and amlodipine treatment, the treatment effect of the two groups were compared. Results: After treatment, the SBP and DBP levels in both groups were significantly better than those before treatment (P <0.05). After treatment, SBP and DBP levels and serum uric acid in the observation group were better than those in the control group. The total effective rate of treatment group was higher than that of control group. Conclusion: Clinical application of irbesartan and amlodipine in the treatment of type 2 diabetes mellitus with hypertension and hyperuricemia has a good clinical effect, which can effectively control the status of blood sugar, blood pressure and serum uric acid in patients with type 2 diabetes and enhance the renal function Protection, it is worth to apply.